1.16
price down icon5.69%   -0.07
after-market アフターアワーズ: 1.15 -0.01 -0.86%
loading
前日終値:
$1.23
開ける:
$1.19
24時間の取引高:
109.91K
Relative Volume:
0.25
時価総額:
$70.24M
収益:
$2.91M
当期純損益:
$-220.40M
株価収益率:
-0.3187
EPS:
-3.64
ネットキャッシュフロー:
$-176.15M
1週間 パフォーマンス:
-9.38%
1か月 パフォーマンス:
-7.94%
6か月 パフォーマンス:
-92.21%
1年 パフォーマンス:
-87.15%
1日の値動き範囲:
Value
$1.1374
$1.23
1週間の範囲:
Value
$1.11
$1.30
52週間の値動き範囲:
Value
$1.11
$22.50

Igm Biosciences Inc Stock (IGMS) Company Profile

Name
名前
Igm Biosciences Inc
Name
セクター
Healthcare (1182)
Name
電話
650-965-7873
Name
住所
325 E MIDDLEFIELD ROAD, MOUNTAIN VIEW
Name
職員
0
Name
Twitter
Name
次回の収益日
2025-03-31
Name
最新のSEC提出書
Name
IGMS's Discussions on Twitter

IGMS を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
IGMS
Igm Biosciences Inc
1.16 70.24M 2.91M -220.40M -176.15M -3.64
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.01 125.55B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
610.64 67.78B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
590.06 36.24B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
262.16 33.99B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
264.32 28.77B 3.81B -644.79M -669.77M -6.24

Igm Biosciences Inc Stock (IGMS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-10 ダウングレード BMO Capital Markets Outperform → Market Perform
2025-01-10 ダウングレード Guggenheim Buy → Neutral
2025-01-10 ダウングレード Morgan Stanley Equal-Weight → Underweight
2025-01-10 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2025-01-10 ダウングレード Stifel Buy → Hold
2024-12-06 開始されました BMO Capital Markets Outperform
2024-10-01 ダウングレード JP Morgan Neutral → Underweight
2024-10-01 ダウングレード Truist Buy → Hold
2024-02-09 アップグレード RBC Capital Mkts Sector Perform → Outperform
2023-12-15 ダウングレード BofA Securities Buy → Neutral
2023-12-07 ダウングレード H.C. Wainwright Buy → Neutral
2022-11-09 再開されました Jefferies Buy
2022-10-17 開始されました JP Morgan Neutral
2022-08-29 開始されました BofA Securities Buy
2021-12-13 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2021-11-05 アップグレード Wedbush Neutral → Outperform
2021-08-26 開始されました Morgan Stanley Overweight
2021-01-29 開始されました RBC Capital Mkts Outperform
2021-01-19 繰り返されました H.C. Wainwright Buy
2020-12-22 ダウングレード Wedbush Outperform → Neutral
2020-07-17 開始されました Robert W. Baird Outperform
2020-07-01 開始されました H.C. Wainwright Buy
2020-05-28 開始されました SunTrust Buy
2020-04-22 開始されました Wedbush Outperform
2019-10-14 開始されました Guggenheim Buy
2019-10-14 開始されました Jefferies Buy
2019-10-14 開始されました Piper Jaffray Overweight
2019-10-14 開始されました Stifel Buy
すべてを表示

Igm Biosciences Inc (IGMS) 最新ニュース

pulisher
03:44 AM

Short Interest in IGM Biosciences, Inc. (NASDAQ:IGMS) Decreases By 19.3% - MarketBeat

03:44 AM
pulisher
Apr 02, 2025

IGMS STOCK ALERT: Levi & Korsinsky Notifies IGM Biosciences, Inc. Investors of an Ongoing Investigation - ACCESS Newswire

Apr 02, 2025
pulisher
Mar 31, 2025

IGMS stock plunges to 52-week low at $1.14 amid market challenges By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 31, 2025

Charles Schwab Investment Management Inc. Buys 9,441 Shares of IGM Biosciences, Inc. (NASDAQ:IGMS) - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

IGMS stock plunges to 52-week low at $1.14 amid market challenges - Investing.com

Mar 31, 2025
pulisher
Mar 29, 2025

IGM Biosciences (NASDAQ:IGMS) Shares Up 5.9%What's Next? - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

IGM Biosciences stock plunges to 52-week low of $1.59 - MSN

Mar 28, 2025
pulisher
Mar 28, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Given Average Rating of "Reduce" by Brokerages - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives $5.50 Consensus PT from Brokerages - Defense World

Mar 28, 2025
pulisher
Mar 25, 2025

IGM Biosciences (NASDAQ:IGMS) Shares Up 5.9% – Here’s Why - Defense World

Mar 25, 2025
pulisher
Mar 19, 2025

IGM Biosciences CEO Mary Beth Harler sells $9,014 in stock By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

IGM Biosciences CFO Tahir Misbah sells shares worth $9,014 By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

IGM Biosciences chief business officer sells $5,549 in stock By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

IGM Biosciences CEO Mary Beth Harler sells $9,014 in stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

IGM Biosciences chief business officer sells $5,549 in stock - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

IGM Biosciences CFO Tahir Misbah sells shares worth $9,014 - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Igm biosciences officer sells shares worth $2,092 - Investing.com India

Mar 18, 2025
pulisher
Mar 18, 2025

Igm biosciences officer sells shares worth $2,092 By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

IGM Biosciences stock plunges to 52-week low at $1.17 By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

IGM Biosciences stock plunges to 52-week low at $1.17 - Investing.com India

Mar 17, 2025
pulisher
Mar 08, 2025

IGM Biosciences Faces Uncertainty Amid Cash Preservation and Restructuring Efforts - TipRanks

Mar 08, 2025
pulisher
Mar 07, 2025

IGM Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 07, 2025
pulisher
Mar 05, 2025

Contrasting IGM Biosciences (NASDAQ:IGMS) and Gyre Therapeutics (NASDAQ:GYRE) - Defense World

Mar 05, 2025
pulisher
Mar 04, 2025

IGM Biosciences stock plunges to 52-week low of $1.25 By Investing.com - Investing.com Australia

Mar 04, 2025
pulisher
Mar 03, 2025

IGM Biosciences stock plunges to 52-week low of $1.25 - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

IGM Biosciences Inc expected to post a loss of 74 cents a shareEarnings Preview - TradingView

Mar 03, 2025
pulisher
Mar 02, 2025

IGM Biosciences (IGMS) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Mar 02, 2025
pulisher
Mar 01, 2025

IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

IGM Biosciences, Inc. (NASDAQ:IGMS) Receives Consensus Rating of “Reduce” from Brokerages - Defense World

Feb 28, 2025
pulisher
Feb 25, 2025

Senti Bio Strengthens Leadership Team with Strategic Hires - The Manila Times

Feb 25, 2025
pulisher
Feb 19, 2025

IGM to slash 73% of workforce, halt two drug programs - MSN

Feb 19, 2025
pulisher
Feb 18, 2025

Promising US Penny Stocks To Watch In February 2025 - simplywall.st

Feb 18, 2025
pulisher
Feb 13, 2025

Fierce Biotech Layoff Tracker 2025: Encoded trims 29% of team; Inventiva halves staff - Fierce Biotech

Feb 13, 2025
pulisher
Feb 07, 2025

Layoff Tracker: Viracta, X4 and BMS Detail Current, Upcoming Cuts - BioSpace

Feb 07, 2025
pulisher
Feb 06, 2025

Brokerages Set IGM Biosciences, Inc. (NASDAQ:IGMS) PT at $5.50 - MarketBeat

Feb 06, 2025

Igm Biosciences Inc (IGMS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
大文字化:     |  ボリューム (24 時間):